(Q42224371)

English

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial.

scientific article published on 28 August 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial (English)

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

0 references

type-1 diabetes

0 references

phase II clinical trial

0 references

author name string

Stephen E Gitelman

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Peter A Gottlieb

2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Mark R Rigby

3

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Eric I Felner

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Steven M Willi

5

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Lynda K Fisher

6

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Antoinette Moran

7

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Michael Gottschalk

8

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Wayne V Moore

9

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Ashley Pinckney

10

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Lynette Keyes-Elstein

11

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Sudeepta Aggarwal

12

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Deborah Phippard

13

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Peter H Sayre

14

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Linna Ding

15

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Jeffrey A Bluestone

16

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Mario R Ehlers

17

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

START Study Team

18

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

publication date

28 August 2013

1 reference

Europe PubMed Central

PubMed publication ID

19 October 2017

The Lancet: Diabetes & Endocrinology

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

1

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

4

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

306-316

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Incidence trends for childhood type 1 diabetes in Europe during 1989-2003 and predicted new cases 2005-20: a multicentre prospective registration study

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Genetics, pathogenesis and clinical interventions in type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerogenic immunosuppression for organ transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy--The European Group for Blood and Marrow Transplantation experience

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves β-cell function in Chinese patients with new onset of type 1 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rapamycin/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs β-cell function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune reconstitution following rabbit antithymocyte globulin.

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: case report and literature review

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice

1 reference

https://api.crossref.org/works/10.1016%2FS2213-8587%2813%2970065-2

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/24622416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24622416

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S2213-8587(13)70065-2

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=PMCID:PMC6489466&resulttype=core&format=json

14 May 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42224371&oldid=1566668419"